Distribution of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer

Histopathology

Volumn 60, Issue 4, 2012, Pages 617-633

  Isfoss, Björn L ^a,b   Holmqvist, Bo ^b   Alm, Per ^b   Olsson, Håkan ^c  

^a TELEMARK HOSPITAL   (Norway)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

ALDH1; Breast; Histology; Immunohistochemistry; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD24 ANTIGEN; CONTRACTILE PROTEIN; ESTROGEN RECEPTOR ALPHA; HERMES ANTIGEN; KI 67 ANTIGEN; MYOSIN HEAVY CHAIN; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CELL DENSITY; CELL DIFFERENTIATION; CELL NUCLEUS; CELL POPULATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STROMA;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; ISOENZYMES; MAMMARY GLANDS, HUMAN; MIDDLE AGED; RETINAL DEHYDROGENASE; STEM CELLS;

EID: 84857357739     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04109.x     Document Type: Article

References (39)

1. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006; 66; 9339-9344.
2. Schackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439; 84-88.
3. Costello RT, Mallet F, Gaugler B et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dentritic cell transformation capacities. Cancer Res. 2000; 60; 4404-4411.
4. Alvi AJ, Clayton H, Joshi C et al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 2003; 5; R1-R8.
5. Al-Hajj M, Wicha MS, Benito-Hernadez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 2003; 100; 3983-3988.
6. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1; 555-567.
7. Park SY, Hee EL, Hailun L, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin. Cancer Res. 2010; 16; 876-887.
8. Mercato P, Dean CA, Pan D et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011; 29; 32-45.
9. Brisken C, Duss S. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 2007; 3; 147-156.
10. Stingl J. Detection and analysis of mammary gland stem cells. J. Pathol. 2009; 217; 229-241.
11. Chepko G, Slack R, Carbott D, Khan S, Steadman L, Dickson RB. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. Tissue Cell 2005; 37; 393-412.
12. Retsekova E, Reis-Filho JS, Jain RK et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res. Treat. 2010; 123; 97-108.
13. Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ. Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers. Breast Cancer Res. Treat. 2010; 123; 611-612.
14. Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cell Oncol. (Dordr.) 2011; 34; 3-10.
15. Dao TL. Mammary cancer induction by 7, 12-dimethylbenz(a)anthracene: relation to age. Science 1969; 165; 810-811.
16. Rudland PS. Epithelial stem cells and their possible role in the development of the normal and diseased human breast. Histol. Histopathol. 1993; 8; 385-404.
17. Deville P, Tavassoli FA. Tumours of the breast. In Deville P, Tavassoli FA eds. World Health Organization classification of tumor. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press, 2003; 9-112.
18. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl Cancer Inst. 1975; 55; 231-273.
19. Stirling JW, Chandler JA. The fine structure of the normal, resting terminal ductal-lobular unit of the female breast. Virchows Arch. A Pathol. Anat. Histol. 1976; 372; 205-226.
20. Collins LC, Schnitt SJ. Breast. In Mills SE ed. Histology for pathologists, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 1997; 57-71.
21. Russo J, Russo IH. Development of the human mammary gland. In Neville MC, Daniel C eds. The mammary gland. New York: Plenum Publishing, 1987; 67-93.
22. Russo J, Gusterson BA, Rogers AE, Russo IH, Welling SR, Van Zwieten MJ. Comparative study of human and rat mammary tumorigenesis. Lab. Invest. 1990; 62; 244-278.
23. Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS. Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis. Cancer Res. 1996; 56; 402-404.
24. Gerdes J, Lelle RJ, Pickartz H et al. Growth fractions in breast cancers determined insitu with monoclonal antibody Ki-67. J. Clin. Pathol. 1986; 39; 977-980.
25. Makin CA, Bobrow LG, Bodmer WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J. Clin. Pathol. 1984; 37; 975-983.
26. Chiavegato A, Bochaton-Piallat ML, D'Amore E, Sartore S, Gabbiani G. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Arch. 1995; 426; 77-86.
27. Hähnel R, Twaddle E, Vivian AB. Estrogen receptors in human breast cancer. 2. Invitro binding of estradiol by benign and malignant tumors. Steroids 1971; 18; 681-708.
28. Boecker W, Bier B, Freytag G et al. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha smooth muscle actin, vimentin, collagen IV and laminin. Part I: normal breast and benign proliferative lesions. Virchows Arch. A Pathol. Anat. Histopathol. 1992; 421; 315-322.
29. Bhargava R, Dabbs DJ. Immunohistology of metastatic carcinomas of unknown primary. Step 2: the cytokeratins, an overview. In Dabbs DJ ed. Diagnostic immunohistochemistry, 3rd edn. Philadelphia, PA: Saunders Elsevier, 2010; 210-221.
30. Boecker W, Weigel S, Heindel W, Stute P. Preneoplasia of the breast: a new conceptual approach to proliferative breast disease. Munich: Elsevier Saunders, 2006.
31. Werling RW, Hwang H, Yaziji H, Gown AM. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am. J. Surg. Pathol. 2003; 27; 82-90.
32. Huang M, Yuqing L, Huanle Z, Feifei N. Breast cancer stromal fibroblasts promote the generation of CD44+ CD24- cells through SDF-1/CXCR4 interaction. J. Exp. Clin. Cancer Res. 2010; 29; 80.
33. Liu S, Ginestier C, Charafe-Jauffret E et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc. Natl Acad. Sci. USA 2008; 105; 1680-1685.
34. Bánkfalvi A, Ludwig A, de-Hesselle B, Buerger H, Buchwalow IB, Boecker W. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases. Mod. Pathol. 2004; 17; 1051-1061.
35. Tavassoli FA. Myoepithelial lesions of the breast. Myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am. J. Surg. Pathol. 1991; 15; 554-568.
36. Lazard D, Xavier S, Frid MG, Glukhova MA, Thiery J-P. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc. Natl Acad. Sci. USA 1993; 90; 999-1003.
37. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am. J. Surg. Pathol. 2004; 28; 1076-1091.
38. Brisken C, Heineman A, Chavarria T et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000; 14; 650-654.
39. Keeling JW, Ozer E, King G, Walker F. Oestrogen receptor alpha in female fetal, infant, and child mammary tissue. J. Pathol. 2000; 191; 449-451.